1. Contaminated sodium acetate injection USP not recalled in Canada due to shortage

   News item 26 March 2022 Pages: 1 - 1

2. MHRA issues new advice to monitor for liver injury from cladribine treatment

   News item 26 March 2022 Pages: 2 - 2

3. PRAC meeting highlights March 2022

   News item 26 March 2022 Pages: 3 - 3

4. Reminder to monitor for adverse lung, liver and thyroid changes with amiodarone treatment

   News item 26 March 2022 Pages: 4 - 4

5. Revisions of package inserts for efavirenz, nintedanib and ticagrelor

   News item 26 March 2022 Pages: 5 - 5

6. Anticoagulant-related intracranial haemorrhage underreported

   Clinical study 26 March 2022 Pages: 6 - 6

7. Campylobacteriosis may masquerade as ibrutinib-related adverse events

   Clinical study 26 March 2022 Pages: 7 - 7

8. Glatiramer acetate not associated with adverse pregnancy, foetal, or infant outcomes

   Clinical study 26 March 2022 Pages: 8 - 8

9. Risk of major bleeding: DOACs vs LMWH for thromboprophylaxis in non-cardiac surgery

   Review 26 March 2022 Pages: 9 - 9

10. Risk of postoperative hypoxaemia during opioid analgesic shortages

    Clinical study 26 March 2022 Pages: 10 - 10

11. Some sulfonylureas increase risk of MACE in patients with T2DM

    Clinical study 26 March 2022 Pages: 11 - 11

12. Systemic AEs common after COVID-19 vaccination

    Clinical study 26 March 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 26 March 2022 Pages: 13 - 13

14. Acenocoumarol

    Case report 26 March 2022 Pages: 14 - 14

15. Ad26.cov2-s

    Case report 26 March 2022 Pages: 15 - 15

16. Adalimumab

    Case report 26 March 2022 Pages: 16 - 16

17. Adalimumab

    Case report 26 March 2022 Pages: 17 - 17

18. Adalimumab/ciclosporin/prednisone

    Case report 26 March 2022 Pages: 18 - 18

19. Agomelatine/lithium/venlafaxine

    Case report 26 March 2022 Pages: 19 - 19

20. Alitretinoin

    Case report 26 March 2022 Pages: 20 - 20

21. Aluminium-potassium-sulfate/tannic-acid

    Case report 26 March 2022 Pages: 21 - 21

22. Amiodarone

    Case report 26 March 2022 Pages: 22 - 22

23. Amiodarone/epinephrine

    Case report 26 March 2022 Pages: 23 - 23

24. Amiodarone/flecainide/mexiletine

    Case report 26 March 2022 Pages: 24 - 24

25. Amlodipine/atorvastatin/benidipine

    Case report 26 March 2022 Pages: 25 - 25

26. Amlodipine/clonazepam/escitalopram

    Case report 26 March 2022 Pages: 26 - 26

27. Amoxicillin

    Case report 26 March 2022 Pages: 27 - 27

28. Amoxicillin

    Case report 26 March 2022 Pages: 28 - 28

29. Amoxicillin/amoxicillin/clavulanic-acid

    Case report 26 March 2022 Pages: 29 - 29

30. Amphotericin-B

    Case report 26 March 2022 Pages: 30 - 30

31. Anakinra

    Case report 26 March 2022 Pages: 31 - 31

32. Anakinra

    Case report 26 March 2022 Pages: 32 - 32

33. Anakinra/immune-globulin/mycophenolate-mofetil

    Case report 26 March 2022 Pages: 33 - 33

34. Antiarrhythmic drugs

    Case report 26 March 2022 Pages: 34 - 34

35. Antibacterials

    Case report 26 March 2022 Pages: 35 - 35

36. Antibacterials

    Case report 26 March 2022 Pages: 36 - 36

37. Antibiotics

    Case report 26 March 2022 Pages: 37 - 37

38. Antibiotics/immunosuppressants

    Case report 26 March 2022 Pages: 38 - 38

39. Antibiotics/plasma

    Case report 26 March 2022 Pages: 39 - 39

40. Anticoagulants/antiarrhythmics

    Case report 26 March 2022 Pages: 40 - 40

41. Antiepileptic drugs/praziquantel

    Case report 26 March 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 26 March 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 26 March 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 26 March 2022 Pages: 44 - 44

45. Antineoplastics

    Case report 26 March 2022 Pages: 45 - 45

46. Antineoplastics

    Case report 26 March 2022 Pages: 46 - 46

47. Antineoplastics

    Case report 26 March 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 26 March 2022 Pages: 48 - 48

49. Antineoplastics

    Case report 26 March 2022 Pages: 49 - 49

50. Antineoplastics

    Case report 26 March 2022 Pages: 50 - 50